Logo-ijhpm
Int J Health Policy Manag. 2018;7(6): 542-548. doi: 10.15171/ijhpm.2017.122
PMID: 29935131        PMCID: PMC6015511

Original Article

Misuse of Artemisinin Combination Therapies by Clients of Medicine Retailers Suspected to Have Malaria Without Prior Parasitological Confirmation in Nigeria

Ernest Nwokolo 1, Chinazo Ujuju 1, Jennifer Anyanti 1, Chinwoke Isiguzo 1, Ifeanyi Udoye 1, Elamei BongosIkwue 1, Onoriode Ezire 1, Mopelola Raji 1, Wellington A. Oyibo 2 *

Cited by CrossRef:

1- Laktabai J, Saran I, Zhou Y, Simmons R, Turner E, Visser T, O'Meara W. Subsidise the test, the treatment or both? Results of an individually randomised controlled trial of the management of suspected malaria fevers in the retail sector in western Kenya. BMJ Glob Health. 2020;5(11):e003378 [Crossref]
2- Bukenya R, Laborde J, Mamiro P, Mugabi R, Kinabo J. Assessment of nutrient adequacy of complementary foods for infants and young children in Morogoro, Tanzania. Scientific African. 2023;19:e01567 [Crossref]
3- Edwards H, Sarwar R, Mahmud P, Emmanuel S, Maxwell K, Tibenderana J. The impact of the private sector co-payment mechanism (PSCM) on the private market for ACT in Nigeria: results of the 2018 cross-sectional outlet and household market surveys. Malar J. 2022;21(1) [Crossref]
4- Audu D, Patel V, Idowu O, Mshelbwala F, Idowu A. Baseline and recurrent exposure to the standard dose of artemisinin-based combination therapies (ACTs) induces oxidative stress and liver damage in mice (BALB/c). Egypt Liver Journal. 2023;13(1) [Crossref]
5- Laktabai J, Kimachas E, Kipkoech J, Menya D, Arthur D, Zhou Y, Chepkwony T, Abel L, Robie E, Amunga M, Ambani G, Woldeghebriel M, Garber E, Eze N, Mudabai P, Gallis J, Fashanu C, Saran I, Woolsey A, Visser T, Turner E, Prudhomme O’Meara W, Messenger L. A cluster-randomized trial of client and provider-directed financial interventions to align incentives with appropriate case management in retail medicine outlets: Results of the TESTsmART Trial in western Kenya. PLOS Glob Public Health. 2024;4(2):e0002451 [Crossref]
6- Kaneko T, Hino S, Iijima Y, Horie N. Microscopic Polyangiitis Initially Presumed to Be Endocarditis. Case Reports in Dentistry. 2020;2020:1 [Crossref]
7- Woolsey A, Simmons R, Woldeghebriel M, Zhou Y, Ogunsola O, Laing S, Olaleye T, Kipkoech J, Rojas B, Saran I, Odhiambo M, Malinga J, Ambani G, Kimachas E, Fashanu C, Wiwa O, Menya D, Laktabai J, Visser T, Turner E, O’Meara W. Incentivizing appropriate malaria case management in the private sector: a study protocol for two linked cluster randomized controlled trials to evaluate provider- and client-focused interventions in western Kenya and Lagos, Nigeria. Implementation Sci. 2021;16(1) [Crossref]
8- Edwards H, Sarwar R, Mahmud P, Emmanuel S, Maxwell K, Tibenderana J. The private sector market for malaria rapid diagnostic tests in Nigeria: results of the 2018 market survey. Malar J. 2022;21(1) [Crossref]
9- Woldeghebriel M, Aso E, Berlin E, Fashanu C, Kirumira S, Lam F, Mugerwa R, Nakiganda J, Olaleye T, Opigo J, Osinupebi F, Priestley N, Stringham R, Uhomoibhi P, Visser T, Ward A, Wiwa O, Woolsey A. Assessing availability, prices, and market share of quality-assured malaria ACT and RDT in the private retail sector in Nigeria and Uganda. Malar J. 2024;23(1) [Crossref]
10- Shuai Y, Wang J, Jiang H, Yu Y, Jin L. Oral‐maxillofacial adverse events related to antimalarials. Oral Diseases. 2021;27(6):1376 [Crossref]
11- Iribhogbe O, Odoya E. Self‐medication practice with antimalarials & the determinants of malaria treatment‐seeking behavior among postpartum mothers in a rural community in Nigeria. Pharmacoepidemiology and Drug. 2021;30(4):435 [Crossref]
12- Adum P, Agyare V, Owusu-Marfo J, Agyeman Y. Knowledge, attitude and practices of malaria preventive measures among mothers with children under five years in a rural setting of Ghana. Malar J. 2023;22(1) [Crossref]
13- Audu D, Olufunmilayo Ajoke I, Fakilahyel Musa M, Adewumi Babatunde I. Effects of long-term repeated treatment with artemisinin-based combination therapy on the reproductive potential of male mice. Physiol Pharmacol. 2024;28(3):271 [Crossref]
14- Schäfer T, Pessanha de Carvalho L, Inoue J, Kreidenweiss A, Held J. The problem of antimalarial resistance and its implications for drug discovery. Expert Opinion on Drug Discovery. 2024;19(2):209 [Crossref]